相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Asian Ethnicity and Femoral Geometry in Atypical Femur Fractures: Independent or Interdependent Risk Factors?
Nitesh D. Dhanekula et al.
JBMR PLUS (2022)
Stressed volume estimated by finite element analysis predicts the fatigue life of human cortical bone: The role of vascular canals as stress concentrators
L. L. Loundagin et al.
BONE (2021)
Biomechanical mechanisms of atypical femoral fracture
Ani Ural
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2021)
Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women With Osteoporosis in the Phase 3 Long-Term Odanacatib Fracture Trial
Socrates Papapoulos et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Dose-dependent effects of pharmaceutical treatments on bone matrix properties in ovariectomized rats
Lamya Karim et al.
BONE REPORTS (2021)
Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in typical atypical subtrochanteric femoral fracture: A proposed theory of atypical femoral fracture subtypes
Yoto Oh et al.
BONE (2020)
Fifty years of bisphosphonates: What are their mechanical effects on bone?
David B. Burr
BONE (2020)
Association between intracortical microarchitecture and the compressive fatigue life of human bone: A pilot study
Lindsay L. Loundagin et al.
BONE REPORTS (2020)
Stressed volume around vascular canals explains compressive fatigue life variation of secondary osteonal bone but not plexiform bone
L. L. Loundagin et al.
JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS (2020)
Relationship Between Bone Mineral Density T-Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment
S. Ferrari et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Spontaneous Insufficiency Fractures
M. Brennan et al.
JOURNAL OF NUTRITION HEALTH & AGING (2019)
Influence of geometry on proximal femoral shaft strains: Implications for atypical femoral fracture
Ifaz T. Haider et al.
BONE (2018)
Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication
Stuart Silverman et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2018)
Understanding Bone Strength Is Not Enough
Christopher J. Hernandez et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance
Ashley A. Lloyd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Letter to the Editor regarding Bajaj D, et al., The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate, Bone 2014;64:57-64
Amy Courtney et al.
BONE (2016)
Response to letter to the editor by Leder et al. regarding commentary Concurrent administration of PTH and antiresorptives: Additive effects or DXA cosmetics Response
Devendra Bajaj et al.
BONE (2016)
Incidence and Characteristics of Atypical Femoral Fractures: Clinical and Geometrical Data
Zeineb Mahjoub et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
A Crisis in the Treatment of Osteoporosis
Sundeep Khosla et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analyses
Eric Lespessailles et al.
BONEKEY REPORTS (2016)
Risk of atypical femoral fracture during and after bisphosphonate use Full report of a nationwide study
Jorg Schilcher et al.
ACTA ORTHOPAEDICA (2015)
Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs
David B. Burr et al.
BONE (2015)
Alendronate treatment alters bone tissues at multiple structural levels in healthy canine cortical bone
Claire Acevedo et al.
BONE (2015)
Comparison of proximal femur and vertebral body strength improvements in the FREEDOM trial using an alternative finite element methodology
Philippe Zysset et al.
BONE (2015)
Effects of Denosumab, Alendronate, or Denosumab Following Alendronate on Bone Turnover, Calcium Homeostasis, Bone Mass and Bone Strength in Ovariectomized Cynomolgus Monkeys
Paul J. Kostenuik et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2015)
The resistance of cortical bone tissue to failure under cyclic loading is reduced with alendronate
Devendra Bajaj et al.
BONE (2014)
Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: Mechanical analysis by the CT-based finite element method
Yoto Oh et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2014)
Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research
Elizabeth Shane et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Clinical Trials Express: Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)
Toshitaka Nakamura et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Dichotomous location of 160 atypical femoral fractures
Veronika A. Koeppen et al.
ACTA ORTHOPAEDICA (2013)
Effects of minodronic acid and alendronate on bone remodeling, microdamage accumulation, degree of mineralization and bone mechanical properties in ovariectomized cynomolgus monkeys
Yoshiki Yamagami et al.
BONE (2013)
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX
Eugene V. McCloskey et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures
Eve Donnelly et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Decreased bone remodeling and porosity are associated with improved bone strength in ovariectomized cynomolgus monkeys treated with denosumab, a fully human RANKL antibody
Paul J. Kostenuik et al.
BONE (2011)
Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys
Michael S. Ominsky et al.
BONE (2011)
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
Samuel Gourion-Arsiquaud et al.
BONE (2010)
BoneJ Free and extensible bone image analysis in ImageJ
Michael Doube et al.
BONE (2010)
Microarchitectural Deterioration of Cortical and Trabecular Bone: Differing Effects of Denosumab and Alendronate
Ego Seeman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
A Longitudinal HR-pQCT Study of Alendronate Treatment in Postmenopausal Women With Low Bone Density: Relations Among Density, Cortical and Trabecular Microarchitecture, Biomechanics, and Bone Turnover
Andrew J. Burghardt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
Jacques P. Brown et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method
K. Imai et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment
Matthew R. Allen et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
M. R. Allen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
Matthew R. Allen et al.
BONE (2006)
Comparison of the elastic and yield properties of human femoral trabecular and cortical bone tissue
HH Bayraktar et al.
JOURNAL OF BIOMECHANICS (2004)
Insufficiency fracture. A survey of 60 cases and review of the literature
M Soubrier et al.
JOINT BONE SPINE (2003)
Correlation of bone mineral density with strength and microstructural parameters of cortical bone in vitro
NJ Wachter et al.
BONE (2002)
Diagnosis of osteoporosis and assessment of fracture risk
JA Kanis
LANCET (2002)
Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women
P Roschger et al.
BONE (2001)
Tensile fatigue in bone: are cycles-, or time to failure, or both, important?
P Zioupos et al.
JOURNAL OF THEORETICAL BIOLOGY (2001)
Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys
DB Burr et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2001)
分享论文
